Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunity to COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Not applicableStudy completedNCT04562285
What this trial is testing

Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays

Who this might be right for
Covid19
Henry Ford Health System 829
Testing effectiveness (Phase 2)UnknownNCT04748471
What this trial is testing

Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y)

Who this might be right for
Prevention of COVID19
Assistance Publique - Hôpitaux de Paris 180
Early research (Phase 1)Looking for participantsNCT07464314
What this trial is testing

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

Who this might be right for
Influenza, Human+COVID-19
GlaxoSmithKline 225
Not applicableStudy completedNCT04494893
What this trial is testing

ImmuneRACE - Immune Response Action to COVID-19 Events

Who this might be right for
Covid19
Adaptive Biotechnologies 808
Early research (Phase 1)Study completedNCT05972993
What this trial is testing

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

Who this might be right for
COVID-19
GlaxoSmithKline 114
Not applicableStudy completedNCT04431414
What this trial is testing

Immune Responses to the Virus That Causes COVID-19

Who this might be right for
SARS-CoV-2COVID-19
COVID-19 Prevention Network 953
Testing effectiveness (Phase 2)Study completedNCT07408297
What this trial is testing

Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda

Who this might be right for
COVID -19SARS CoV 2 Infection
Victoria Biomedical Research Institute 1,919
Large-scale testing (Phase 3)Study completedNCT05047770
What this trial is testing

A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

Who this might be right for
Herpes Zoster
GlaxoSmithKline 2,013
Testing effectiveness (Phase 2)Study completedNCT05205746
What this trial is testing

Phase II Study of AVX/COVID-12 Vaccine in Subjects With Prior SARS-CoV-2 Immunity Evidence

Who this might be right for
SARS CoV 2 Infection
Laboratorio Avi-Mex, S.A. de C.V. 158
Not applicableStudy completedNCT04370119
What this trial is testing

Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers

Who this might be right for
SARS-CoV-2
University Medicine Greifswald 1,092
Early research (Phase 1)Looking for participantsNCT06821100
What this trial is testing

Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine

Who this might be right for
Vaccine ResponseCOVID-19 VaccineImmune Response to Covid 19 Vaccination
The Methodist Hospital Research Institute 75